Luo HY - Search Results

Year	Number of Results
1958	1
1960	1
1981	2
1982	3
1983	5
1984	6
1985	4
1986	7
1987	6
1988	4
1989	1
1990	1
1991	6
1992	1
1993	2
1994	1
1995	3
1999	1
2000	2
2001	2
2002	9
2003	8
2004	15
2005	11
2006	23
2007	19
2008	14
2009	18
2010	21
2011	19
2012	27
2013	31
2014	24
2015	32
2016	40
2017	23
2018	32
2019	32
2020	18
2021	22
2022	42
2023	39
2024	35
2025	42

1

CAF-macrophage crosstalk in tumour microenvironments governs the response to immune checkpoint blockade in gastric cancer peritoneal metastases.

Li Y, Zheng Y, Huang J, Nie RC, Wu QN, Zuo Z, Yuan S, Yu K, Liang CC, Pan YQ, Zhao BW, Xu Y, Zhang Q, Zheng Y, Chen J, Zeng ZL, Wei W, Liu ZX, Xu RH, Luo HY. Li Y, et al. Among authors: luo hy. Gut. 2025 Feb 6;74(3):350-363. doi: 10.1136/gutjnl-2024-333617. Gut. 2025. PMID: 39537239 Free PMC article. Clinical Trial.

2

Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response.

Zhang Z, Wang ZX, Chen YX, Wu HX, Yin L, Zhao Q, Luo HY, Zeng ZL, Qiu MZ, Xu RH. Zhang Z, et al. Among authors: luo hy. Genome Med. 2022 Apr 29;14(1):45. doi: 10.1186/s13073-022-01050-w. Genome Med. 2022. PMID: 35488273 Free PMC article.

3

Cdo1-Camkk2-AMPK axis confers the protective effects of exercise against NAFLD in mice.

Chen M, Zhu JY, Mu WJ, Luo HY, Li Y, Li S, Yan LJ, Li RY, Guo L. Chen M, et al. Among authors: luo hy. Nat Commun. 2023 Dec 18;14(1):8391. doi: 10.1038/s41467-023-44242-7. Nat Commun. 2023. PMID: 38110408 Free PMC article.

4

Dynamic single-cell mapping unveils Epstein‒Barr virus-imprinted T-cell exhaustion and on-treatment response.

Qiu MZ, Wang C, Wu Z, Zhao Q, Zhao Z, Huang CY, Wu W, Yang LQ, Zhou ZW, Zheng Y, Pan HM, Liu Z, Zeng ZL, Luo HY, Wang F, Wang FH, Yang SY, Huang MX, Lian Z, Zhang H, Xu RH. Qiu MZ, et al. Among authors: luo hy. Signal Transduct Target Ther. 2023 Sep 21;8(1):370. doi: 10.1038/s41392-023-01622-1. Signal Transduct Target Ther. 2023. PMID: 37735150 Free PMC article.

5

System X_c ^-/GSH/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy.

Li FJ, Long HZ, Zhou ZW, Luo HY, Xu SG, Gao LC. Li FJ, et al. Among authors: luo hy. Front Pharmacol. 2022 Aug 29;13:910292. doi: 10.3389/fphar.2022.910292. eCollection 2022. Front Pharmacol. 2022. PMID: 36105219 Free PMC article. Review.

6

Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial.

Wang F, Jin Y, Wang M, Luo HY, Fang WJ, Wang YN, Chen YX, Huang RJ, Guan WL, Li JB, Li YH, Wang FH, Hu XH, Zhang YQ, Qiu MZ, Liu LL, Wang ZX, Ren C, Wang DS, Zhang DS, Wang ZQ, Liao WT, Tian L, Zhao Q, Xu RH. Wang F, et al. Among authors: luo hy. Nat Med. 2024 Apr;30(4):1035-1043. doi: 10.1038/s41591-024-02813-1. Epub 2024 Mar 4. Nat Med. 2024. PMID: 38438735 Clinical Trial.

7

Hepatic Klf10-Fh1 axis promotes exercise-mediated amelioration of NASH in mice.

Luo HY, Mu WJ, Chen M, Zhu JY, Li Y, Li S, Yan LJ, Li RY, Yin MT, Li X, Chen HM, Guo L. Luo HY, et al. Metabolism. 2024 Jun;155:155916. doi: 10.1016/j.metabol.2024.155916. Epub 2024 Apr 13. Metabolism. 2024. PMID: 38615945

8

Comprehensive multi-omics analysis of pyroptosis for optimizing neoadjuvant immunotherapy in patients with gastric cancer.

Wang JB, Gao YX, Ye YH, Zheng QL, Luo HY, Wang SH, Zhang T, Jin QW, Zheng CH, Li P, Lin JX, Chen QY, Cao LL, Yang YH, Huang CM, Xie JW. Wang JB, et al. Among authors: luo hy. Theranostics. 2024 May 5;14(7):2915-2933. doi: 10.7150/thno.93124. eCollection 2024. Theranostics. 2024. PMID: 38773976 Free PMC article.

9

Regorafenib plus toripalimab in patients with metastatic colorectal cancer: a phase Ib/II clinical trial and gut microbiome analysis.

Wang F, He MM, Yao YC, Zhao X, Wang ZQ, Jin Y, Luo HY, Li JB, Wang FH, Qiu MZ, Lv ZD, Wang DS, Li YH, Zhang DS, Xu RH. Wang F, et al. Among authors: luo hy. Cell Rep Med. 2021 Aug 27;2(9):100383. doi: 10.1016/j.xcrm.2021.100383. eCollection 2021 Sep 21. Cell Rep Med. 2021. PMID: 34622226 Free PMC article. Clinical Trial.

10

PI3K/AKT Signal Pathway: A Target of Natural Products in the Prevention and Treatment of Alzheimer's Disease and Parkinson's Disease.

Long HZ, Cheng Y, Zhou ZW, Luo HY, Wen DD, Gao LC. Long HZ, et al. Among authors: luo hy. Front Pharmacol. 2021 Apr 15;12:648636. doi: 10.3389/fphar.2021.648636. eCollection 2021. Front Pharmacol. 2021. PMID: 33935751 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

593 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

593 results

Results by year